Savara Inc. (SVRA) intrinsic value & 10-year financials

Savara Inc. (SVRA) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$4.45
Market cap
$989.6M
Revenue (FY2025)
—
Revenue growth (10-yr CAGR)
19.0%
ROIC (10-yr avg)
-93.4%
Free cash flow (FY2025)
-$101.1M

SVRA 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$118.8M -$0.53 -$101.1M — -64.5%
FY2024 — -$95.9M -$0.48 -$89.1M — -63.8%
FY2023 — -$54.7M -$0.33 -$51.4M — -49.2%
FY2022 — -$38.1M -$0.25 -$34.6M — -35.0%
FY2021 — -$43.0M -$0.32 -$40.1M — -42.4%
FY2020 $257.0K -$49.6M — -$39.9M -19182.9% -83.5%
FY2019 $0 -$78.2M — -$45.3M — -149.8%
FY2018 — -$61.5M — -$39.4M — -54.1%
FY2017 $0 -$29.8M — -$28.7M — -41.4%
FY2016 $128.0K -$36.1M — -$37.3M -28481.2% -350.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Savara Inc revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Savara Inc has historically struggled to out-earn its cost of capital, averaging just -58.7% ROIC.

Savara Inc capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Savara Inc is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-17.60 per share.

SVRA stock: frequently asked questions

What is the intrinsic value of Savara Inc. (SVRA) stock?

Graham's formula only works with positive earnings. Savara Inc. reported diluted EPS of -$0.53 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Savara Inc. generate free cash flow?

Savara Inc. generated -$101.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 10 reported years.

What is SVRA's return on invested capital?

Average ROIC over the last 10 fiscal years was -93.4%, and average return on equity was -84.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SVRA data come from?

From Savara Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 12, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks